multilayer tablet exclusion criteria from PK analysis due to emesis [Regulatives / Guidelines]

posted by jag009  – NJ, 2016-01-26 18:56 (3344 d 10:08 ago) – Posting: # 15858
Views: 4,152

❝ Please share your thoughts on that.


I've done a few of those IR/XR or IR/ER bilayer tablets before and emesis was be based on IR. It's one tablet for administration. Why would you based on MR for emesis dropout criteria?

John

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,677 registered users;
18 visitors (0 registered, 18 guests [including 7 identified bots]).
Forum time: 05:04 CET (Europe/Vienna)

There are no routine statistical questions,
only questionable statistical routines.    David R. Cox

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5